debt to equity ratio of the Company was considerably low at 0.28: 1. Financial Highlights 3Q 2017 3Q 2016 Change 9M 2017 9M 2016 Change THB million % Sales THB million % Sales THB million % THB million
fully amortized cost of purchasing 34 36 40 Summary of Profit and Loss Statement 2016 2017 Change MB % MB % MB % Total Revenues 1,063.7 100.0% 1,356.3 100.0% 292.6 27.5% Cost of Services 377.9 35.5% 574.4
2019 shows a net profit of 0.5 million baht, which was higher than the same period from previous year. Thus, the details of the Company’s performance are explained as follows; Q1/2018 Q1/2019 Change MB
Bank’s international network. Million Baht Loans by Business Type * December 2017 September 2017 December 2016 Change (%) September 2017 December 2016 Manufacturing and commercial 819,338 812,621 810,335
Financial Statements 3Q'18 3Q'17 % Change YTD 2018 YTD 2017 % Change Revenue from Sales and Services 443.4 406.2 9.2% 1,288.9 1,199.6 7.4% - Operating Revenue1 423.9 404.2 4.9% 1,264.9 1,165.5 8.5% - Other
Thailand Sustainability Investment 4/ Thailand Sustainability Investment n/a Ranking by Industry Business 4/ Market/Industry/Sector Change Effective Date 02/07/2015 Previous Market/Industry/Sector SET
Utilities and services Housing Real estate and construction Agriculture and mining Others Million Baht Loans by Business Type * March 2018 December 2017 March 2017 Change (%) December 2017 March 2017
-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 1st Quarter 2020 1st Quarter 2019 Change MB % MB % MB % 1. Wellness & Anti-Aging 47.77 49.18 31.87 37.52 15.90 49.90% 2. Aesthetic
Operating Results of the Company in Q3/2019 Q3/18 Q3/19 9M/18 9M/19 Change +/(-) (THB million) YoY 9M Operating Revenue 215 312 45% 620 911 47% Gross Profit 147 202 37% 420 592 41% EBITDA 62 98 58% 161 284 76